Innovations in Healthcare and Technology

Cedars-Sinai is committed to pushing the frontiers of medicine and discovering new technologies and innovations that will change the way we diagnose and treat disease.

Nanotechnology, biomedical imaging, reconstructing model organs from stem cells and precision approaches are a few examples of research collaborations that transcend specific medical specialties. Top scientists in heart, cancer, neurosciences, gastrointestinal disease, metabolic disease and regenerative medicine routinely cooperate at Cedars-Sinai — understanding that with advances in technology and precision medicine, a breakthrough that benefits one condition may apply to many others.

Milestones and Possibilities

  • Stem cells hold great potential not only as therapeutic treatments but also as a platform for new scientific discoveries that will unlock doors to therapies and cures. At the Board of Governors Regenerative Medicine Institute, scientists are creating patient stem cell lines that could aid in uncovering medicines for Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), cancer, stroke and other neurological disorders.
  • Researchers at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute are harnessing the immune system to pursue new approaches to the treatment of melanoma, kidney cancer, pancreatic cancer, ovarian cancer and breast cancer. Investigators are also developing a nanoparticle carrier that can target the delivery of a chemotherapy drug into a tumor and then trigger its release by radiation.
  • Physicians at Cedars-Sinai are exploring how to reduce postoperative pain and complications by using computer-guided spinal navigation to more accurately treat complex tumors and degenerative spine problems.
  • Research that crosses medical specialties has revealed that there is a particular connection between Crohn’s disease — a form of inflammatory bowel disease (IBD) — and the inflammatory spine disorder ankylosing spondylitis (AS), enabling physicians at Cedars-Sinai to find treatments that can benefit both groups of patients.